Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.997
-6.82 %
$ 3.33 M
Market Cap
-0.28
P/E
CASH FLOW STATEMENT
-5.58 M
OPERATING CASH FLOW
-2.83 M
INVESTING CASH FLOW
2.57 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Shuttle Pharmaceuticals Holdings, Inc.
| Net Income | -6.59 M |
| Depreciation & Amortization | 6.81 K |
| Capital Expenditures | -19 K |
| Stock-Based Compensation | 182 K |
| Change in Working Capital | 221 K |
| Others | 669 K |
| Free Cash Flow | -5.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (6.6) | (3.0) | (1.2) | (0.8) | (0.6) | (0.2) |
| Depreciation & Amortization | 6.81 K | 66.8 K | 60.8 K | 55 K | 18 K | 18.7 K |
| Deferred Income Tax | 0 | 0 | (0.6) | 0 | 0 | 0 |
| Stock Based Compensation | 0.2 | 0.4 | 0.9 | 0.5 | 0 | 0 |
| Other Operating Activities | 0.6 | 0.4 | 3.39 K | 0.3 | 63.8 K | 58.5 K |
| Change in Working Capital | 0.2 | (0.6) | 0.5 | 7.78 K | 16.6 K | 9.03 K |
| Cash From Operations | (5.6) | (2.7) | (0.3) | 26.8 K | (0.6) | (0.2) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | 19 K | 0 | 0 | 10.8 K | 0 | 0 |
| Other Items | (2.8) | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (2.8) | 0 | 0 | 10.8 K | 0 | 0 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 2.9 | 0.6 | 0.7 | 70.1 K | 0.2 | 0.2 |
| Dividends Paid | 0 | (0.4) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.3) | 0.4 | 0 | 0 | (0.2) | 0 |
| Cash From Financing Activities | 2.6 | 10.6 | 0.7 | 70.1 K | 0.9 | 0.2 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (5.8) | 7.9 | 0.4 | 32.4 K | 0.3 | 42.1 K |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (5.6) | (2.7) | (0.3) | 37.6 K | (0.6) | (0.2) |